Advances in Alzheimer’s Disease Diagnostics and Therapeutics: A Clinician’s Perspective Murray A. Raskind, MD
Pathophysiology of AD: Foundation Role of Cholinergic Dysregulation and Emerging Perspectives on the Pathobiology of AD James E. Galvin, MD, MPH
Evidence-based Role of Cholinesterase Inhibition Across the Severity Spectrum in AD Sandra E. Black, MD, FRCPC
Translating Advances in Biomarker-based Detection into Clinical Practice: Implications for Current Therapies and Beyond Serge Gauthier, MD
Interactive Question and Answer Session Faculty Panel
